Impact of viral aetiology in the Phase 3 HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) Meeting Abstract
| Authors: | Chan, S. L.; Kudo, M.; Sangro, B.; Kelley, K.; Furuse, J.; Park, J. W.; Sunpaweravong, P.; Fasolo, A.; Yau, T.; Kawaoka, T.; Cheng, A. L.; Azevedo, S.; Reig, M.; Assenat, E.; Yarchoan, M.; He, A. R.; Makowsky, M.; Ran, D.; Negro, A.; Ettrich, T. J.; Abou-Alfa, G. |
| Abstract Title: | Impact of viral aetiology in the Phase 3 HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) |
| Meeting Title: | 36. Deutscher Krebskongress - Fortschritt gemeinsam gestalten |
| Journal Title: | Oncology Research and Treatment |
| Volume: | 47 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Feb 21-24 |
| Meeting Location: | Berlin, Germany |
| ISSN: | 2296-5270 |
| Publisher: | S. Karger AG |
| Date Published: | 2024-02-01 |
| Start Page: | 67 |
| Language: | English |
| ACCESSION: | WOS:001332646400156 |
| PROVIDER: | wos |
| DOI: | 10.1159/000535363 |
| Notes: | Meeting Abstract: 351 -- 'The 36th German Cancer Congress - Building Progress Together' -- Located in the section 'Gastrointestinal Cancer: other than colorectal' -- Source: Wos |
